Anton Osika (@antonosika) is the co-founder and CEO of @lovable, where anyone can build software through conversation.
His working thesis: the most underrated moat in AI is trust, and earning it takes craft, care, and obsession.
Claude Security is now in public beta for Claude Enterprise customers.
Claude scans your codebase for vulnerabilities, validates each finding to cut false positives, and suggests patches you can review and approve.
@maxmarchione Agree with everything you said, but I think the headline claim depends on if they win the biologic status vs peptide for this to hold true.
If you're on Interactive Brokers $IBKR and want to understand your edge better, try using their portfolio analyst tool. You can see your sortino ratio, market correlation, alpha, standard deviation, etc.
Click:
Portfolio analyst
Reports
Create Custom Report (The + sign)
And then pick these options:
Parting thought, everyone jokes about the 20yr at 5.35% while 10s and 30s are ~5.00% and 5.10%… the orphaned 20y is not deliverable into a future for basis trades. It shows you where the real cash market is without trillions of derivs creating liquidity and wagging the cash dog.
@DavidFBailey@scott_lew_is Admire your optimism, but there is no incentive for the trust to unravel, and even if somehow successful, takes away a pillar for a spot ETF.